🚗 #GateSquareCommunityChallenge# Round 2 — Which coin is not listed on Gate Launchpad❓
Time to prove if you’re a true Gate veteran!
💰 Join the challenge — 5 lucky winners will share $50 in GT!
👉 How to participate:
1️⃣ Follow Gate_Square
2️⃣ Like this post
3️⃣ Comment with your answer
🗓️ Deadline: October 8, 2025, 24:00 (UTC+8)
Innovent Biologics: Positive Results from Phase II Clinical Trial of Innovative Drug ICP-488
Jinshi data news on October 9th, Norcheng Jianhua announced in the evening that the company's innovative drug ICP-488 achieved positive clinical trial results in a phase II randomized, double-blind, placebo-controlled study in patients with moderate to severe plaque psoriasis. The results showed that patients treated with 6mg and 9mg (once daily) of ICP-488 had significant improvement in PASI75 at week 12 compared to patients receiving placebo. In addition, the proportion of patients receiving ICP-488 treatment who achieved PASI90, PASI100, and static Physician Global Assessment (sPGA) 0/1 (i.e., complete or near-complete clearance of skin lesions) was significantly higher than that in the placebo group.